Amedisys Inc

Amedisys Inc(AMED)股票分析

$100.990

+0.010 (+0.01%)收盤時

Loading chart…
最高
101.020
開盤
101.020
成交量加權均價
100.98
成交量
1.06M
市值
3.04B
最低
100.930
成交金額
107.04M
企業價值/稅息折舊攤銷前利潤(TTM)
12.17

Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.

分析師評級(11)

上檔空間 +2.24%
持有
5 買進
6 持有
0 賣出
目前: 100.99
最低
101.00
平均
103.25
最高
110.00

RBC Capital

2025-04-16

目標價

$100

買進

Stephens & Co.

2025-03-04

目標價

$101

持有

Stephens & Co.

2025-02-12

目標價

$101

持有

Deutsche Bank

2024-07-31

目標價

$101

持有

Cantor Fitzgerald

2024-07-25

目標價

$101

持有

估值指標

Amedisys Inc(AMED)目前預期本益比為 18.61,5 年平均預期本益比為 21.52。

預期本益比

合理
5 年均值 P/E
21.52
目前P/E
18.61
高估
25.31
低估
17.73

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
14.67
目前EV/EBITDA
12.17
高估
17.33
低估
12.02

預期股價營收比

合理
5 年均值 P/S
1.43
目前P/S
1.21
高估
1.77
低估
1.09

Alphio AI 對 AMED 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%AMED

$104.36

情境價格

基

基準

基準 · 50%AMED

$83.35

情境價格

悲

悲觀

悲觀 · 25%AMED

$78.33

情境價格

AMED 常見問題 —— 由 Alphio AI 解答

Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

11 analysts cover AMED: 5 rate it Buy, 6 Hold and 0 Sell. The average price target is 103.25.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易